Skip to main content
. Author manuscript; available in PMC: 2015 Nov 22.
Published in final edited form as: Am J Clin Exp Obstet Gynecol. 2015 Feb 15;2(1):39–44.

Table 1.

Number of cases per 1000, as calculated using the number of affected individuals in FOCR and estimates of affected individuals from SEER and the population estimates from the 2010 U.S. Census

Disease Site FOCR SEER P-value

# Affected Database Population Cases per 1000 # Affected USCB Population Cases per 1000
Bladder 115 50454 2.29 571518 308745538 1.85 < 0.01
CNS 226 50454 4.5 144463 308745538 .47 < 0.01
Cervical 191 25917 7.37 249632 156964212 1.6 < 0.01
Colorectal 819 50454 16.2 1162426 308745538 3.78 < 0.01
Liver 184 50454 3.65 45942 308745538 0.15 < 0.01
Lung 768 50454 15.2 402326 308745538 1.3 < 0.01
Pancreas 206 50454 4.1 43538 308745538 0.14 < 0.01
Prostate 580 23041 25.2 2707821 151781326 17.8 < 0.01
Stomach 311 50454 6.2 74035 308745538 0.24 < 0.01
Uterine 308 25917 11.9 610804 156964212 3.9 < 0.01
Ovary 5421 25917 209.2 188867 156964212 1.2 *
Breast 2017 25917 77.8 2899726 156964212 18.4 *
*

P-values not calculated for these statistics because of bias apparent secondary to the fact that the index person for each pedigree qualifies by meeting criteria of familial ovarian cancer syndrome, and therefore a high proportion of these will also have breast cancer secondary to BRCA mutations.